Amerisource Health Services recalls Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications. Affected lots have expired by 03/31/2023 or 02/28/2023. Discard or contact for replacement.
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Take action
Contact the company
📍Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
“Metoprolol Succinate 50mg Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/34008-metoprolol-succinate-50mg-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0269-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0269-2023%22&limit=1).
The FDA announced on Jan. 11, 2023, that Amerisource Health Services LLC is recalling Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications. The recall involves products manufactured by Alkem Laboratories Ltd. for BluePoint Laboratories.
The recall is being initiated due to failed dissolution specifications. This action supports the manufacturer's recall which included lots packaged for BluePoint Laboratories.
Context
GovInfoNow's records show Amerisource Health Services LLC has had 30 other recalls since July 27, 2022. Recent brand recalls include a May 1, 2026 recall of Primidone Tablets for cross-contamination risk and a March 16, 2026 recall of Meclizine 12.5mg Tablets for failed tablet specifications. Other recent recalls of similar products include Teva's Jan. 29, 2026 recalls of Metoprolol Succinate tablets due to failed dissolution specifications.
How to tell if you have this one
Check for the 100-count bottle (NDC 68001-501-00) or 500-count bottle (NDC 68001-501-03) with lot numbers 21143211 (expiring 03/31/2023) or 21143185/21143193 (expiring 02/28/2023).
Brand
Amerisource Health Services
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the bottle size and lot number to confirm if your product is affected.
Discard or Contact
If affected, discard the product or contact Amerisource Health Services for a replacement.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0269-2023 (January 11, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0269-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.